ECGI in atrial fibrillation: A clinician's wish list
Related Experiment Videos
Joaquin Azpilicueta1, Mikhail Chmelevsky2, Danila Potyagaylo1
1EP Solutions SA, Yverdon-les-Bains, Switzerland.
Insights
Atrial fibrillation (AFIB) treatments face credibility challenges with high failure rates. Electrocardiographic imaging (ECGI) may improve success rates and patient selection for cardiac ablation therapies.
Area of Science:
- Cardiology
- Medical Imaging
- Health Economics
Background:
- Atrial fibrillation (AFIB) affects 600,000 people annually in the EU, with only 100,000 undergoing invasive treatment.
- Current AFIB invasive treatments have a ~40% failure rate, leading to increased hospitalizations and significant healthcare costs (over 1% of EU healthcare expenditure).
- Variable referral and indication rates for cardiac ablation across the EU highlight a need for improved therapeutic strategies.
Purpose of the Study:
- To evaluate the potential of electrocardiographic imaging (ECGI) to address credibility challenges in invasive AFIB treatment.
- To explore how ECGI can enhance the success rates and efficiency of cardiac ablation therapies.
- To assess ECGI's role in improving patient selection, therapy planning, personalization, and follow-up for AFIB patients.
Main Methods:
- This study is a reflection and analysis of current AFIB treatment outcomes and the potential application of ECGI.
- Literature review and data analysis on AFIB incidence, treatment failure rates, healthcare costs, and current ablation practices.
- Conceptual framework development for integrating ECGI into AFIB management pathways.
Main Results:
- High failure rates (~40%) in current invasive AFIB treatments necessitate improved approaches.
- Significant healthcare burden associated with AFIB, including doubled hospitalizations and tripled re-hospitalizations for untreated patients.
- ECGI presents a potential solution for optimizing patient selection and improving procedural success in cardiac ablation.
Conclusions:
- ECGI offers a promising avenue to enhance the efficacy and accessibility of cardiac ablation for atrial fibrillation.
- Implementing ECGI can lead to more personalized and effective AFIB treatment strategies.
- Addressing the credibility challenge in AFIB treatment requires innovative solutions like ECGI for better patient outcomes and resource utilization.
Abstract:
Have we a challenge of credibility in the invasive treatment of atrial fibrillation (AFIB)? The incidence of AFIB in the European Union (EU) is about 600,000 cases per year, while only 100,000 get an invasive treatment with a failure rate of close to 40%. Those that remain in AFIB need two times more hospitalizations and three times more re-hospitalizations. AFIB accounts for over 1% of the EU health care costs. Too many patients are not referred and the indication rates of cardiac ablation are inexplicably variable throughout the EU. A reflection is made on how electrocardiographic imaging (ECGI) can contribute to bringing the therapy to an advanced level by achieving a higher success rate, efficiently increasing access to ablation therapies, a better patient selection and therapy planning, personalization and follow up.